Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions

The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular Complications

(2018) Daniel J. Drucker   DIABETES

Glucagon-Like Peptide-1 and its Cleavage Products are Renoprotective in Murine Diabetic Nephropathy

(2018) Moellmann Julia et al.   DIABETES

Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs

(2018) Giuseppe Patti et al.   Nature Reviews Cardiology

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

(2018)   NEW ENGLAND JOURNAL OF MEDICINE

A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding

(2018) Constance C. F. M. J. Baaten et al.   BLOOD

Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression

(2018) Benjamin J. Schmiedel et al.   CELL

High-throughput elucidation of thrombus formation reveals sources of platelet function variability

(2018) Johanna P. van Geffen et al.   HAEMATOLOGICA

Platelet biology and functions: new concepts and clinical perspectives

(2018) Paola E. J. van der Meijden et al.   Nature Reviews Cardiology

ProteomicsDB

(2017) Tobias Schmidt et al.   NUCLEIC ACIDS RESEARCH

Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation

(2017) Cristina Barale et al.   THROMBOSIS AND HAEMOSTASIS

Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice

(2016) Sebastian Steven et al.   BRITISH JOURNAL OF PHARMACOLOGY

Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis

(2016) Alison Cameron-Vendrig et al.   DIABETES

DPP4 in Cardiometabolic Disease: Recent Insights From the Laboratory and Clinical Trials of DPP4 Inhibition

(2015) J. Zhong et al.   CIRCULATION RESEARCH

The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis

(2015) Yannick Waumans et al.   Frontiers in Immunology

DPP4 in diabetes

(2015) Diana Röhrborn   Frontiers in Immunology

Supporting Roles of Platelet Thrombospondin-1 and CD36 in Thrombus Formation on Collagen

(2014) Marijke J.E. Kuijpers et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cardiovascular Actions of Incretin-Based Therapies

(2014) John R. Ussher et al.   CIRCULATION RESEARCH

GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?

(2014) S. Brunton   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Identification of platelet function defects by multi-parameter assessment of thrombus formation

(2014) Susanne M. de Witt et al.   Nature Communications

Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis

(2013) Veerle Matheeussen et al.   BASIC RESEARCH IN CARDIOLOGY

Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry

(2013) Marisa Ninivaggi et al.   THROMBOSIS AND HAEMOSTASIS

The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways

(2012) J. M. Burkhart et al.   BLOOD

Fiji: an open-source platform for biological-image analysis

(2012) Johannes Schindelin et al.   NATURE METHODS

Sitagliptin: Anti-platelet effect in diabetes and healthy volunteers

(2012) Ashish Kumar Gupta et al.   PLATELETS

Platelet-Derived Chemokines in Vascular Remodeling and Atherosclerosis

(2010) Rory Koenen et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Enzyme Activity and Immunohistochemical Localization of Dipeptidyl Peptidase 8 and 9 in Male Reproductive Tissues

(2009) Véronique Dubois et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY